FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:938-952 September 28, 2000 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

More than 100 years has passed since Charcot, Carswell, Cruveilhier, and others described the clinical and pathological characteristics of multiple sclerosis.¹ This enigmatic, relapsing, and often eventually progressive disorder of the white matter of the central nervous system continues to challenge investigators trying to understand the pathogenesis of the disease and prevent its progression.² There are 250,000 to 350,000 patients with multiple sclerosis in the United States.³ Multiple sclerosis typically begins in early adulthood and has a variable prognosis. Fifty percent of patients will need help walking within 15 years after the onset of disease.⁴ Advanced magnetic resonance imaging (MRI) . . . [Full Text of this Article]

Clinical Course and Diagnosis

Epidemiologic Features

Genetic Factors

Pathological Features and Pathogenesis

Treatment

Principles of Therapy

Relapses

Relapsing Multiple Sclerosis

Secondary Progressive Multiple Sclerosis

Primary Progressive Multiple Sclerosis and the Management of Symptoms

Treatment of Complications

Challenges in Conducting Clinical Trials and Future Directions

Source Information

From the Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minn.

Address reprint requests to Dr. Noseworthy at the Department of Neurology, Mayo Clinic and Mayo Foundation, 200 First St., SW, Rochester, MN 55905.

References

This article has been cited by other articles:

• Veugelers, P., Fisk, J., Brown, M., Stadnyk, K., Sketris, I., Murray, T., Bhan, V. (2009). Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation. Mult Scler 15: 1286-1294 [Abstract]  
• Trabattoni, D., Saresella, M., Pacei, M., Marventano, I., Mendozzi, L., Rovaris, M., Caputo, D., Borelli, M., Clerici, M. (2009). Costimulatory Pathways in Multiple Sclerosis: Distinctive Expression of PD-1 and PD-L1 in Patients with Different Patterns of Disease. J. Immunol. 183: 4984-4993 [Abstract] [Full Text]  
• Garcea, O., Villa, A., Caceres, F., Adoni, T., Alegria, M., Barbosa Thomaz, R., Buzo, R., Llamas Lopez, L., Rivera Kindel, M. (2009). Early treatment of multiple sclerosis: a Latin American Experts Meeting. Mult Scler 15: S1-S12 [Abstract]  
• Cepok, S., Schreiber, H., Hoffmann, S., Zhou, D., Neuhaus, O., von Geldern, G., Hochgesand, S., Nessler, S., Rothhammer, V., Lang, M., Hartung, H.-P., Hemmer, B. (2009). Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis. Arch Neurol 66: 1216-1223 [Abstract] [Full Text]  
• Etemadifar, M, Fatehi, F, Sahraian, M., Borhanihaghighi, A, Ardestani, P., Kaji-Esfahani, M, Maghzi, A. (2009). Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran. Mult Scler 15: 1126-1130 [Abstract]  
• Rojas, M. A., Carlson, N. G., Miller, T. L., Rose, J. W. (2009). Long-term daclizumab therapy in relapsing-remitting multiple sclerosis. Therapeutic Advances in Neurological Disorders 2: 291-297 [Abstract]  
• Langer-Gould, A., Huang, S. M., Gupta, R., Leimpeter, A. D., Greenwood, E., Albers, K. B., Van Den Eeden, S. K., Nelson, L. M. (2009). Exclusive Breastfeeding and the Risk of Postpartum Relapses in Women With Multiple Sclerosis. Arch Neurol 66: 958-963 [Abstract] [Full Text]  
• Sadovnick, A. D., Yee, I. M., Guimond, C., Reis, J., Dyment, D. A., Ebers, G. C. (2009). Age of Onset in Concordant Twins and Other Relative Pairs With Multiple Sclerosis. Am J Epidemiol 170: 289-296 [Abstract] [Full Text]  
• Weinger, J. G., Omari, K. M., Marsden, K., Raine, C. S., Shafit-Zagardo, B. (2009). Up-Regulation of Soluble Axl and Mer Receptor Tyrosine Kinases Negatively Correlates with Gas6 in Established Multiple Sclerosis Lesions. Am. J. Pathol. 175: 283-293 [Abstract] [Full Text]  
• Hawkes, C., Macgregor, A. (2009). Twin studies and the heritability of MS: a conclusion. Mult Scler 15: 661-667 [Abstract]  
• Lode, K, Bru, E, Klevan, G, Myhr, K., Nyland, H, Larsen, J. (2009). Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis. Mult Scler 15: 638-643 [Abstract]  
• Kalyvas, A., Baskakis, C., Magrioti, V., Constantinou-Kokotou, V., Stephens, D., Lopez-Vales, R., Lu, J.-Q., Yong, V. W., Dennis, E. A., Kokotos, G., David, S. (2009). Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis. Brain 132: 1221-1235 [Abstract] [Full Text]  
• Correale, J., Ysrraelit, M. C., Gaitan, M. I. (2009). Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 132: 1146-1160 [Abstract] [Full Text]  
• Serres, S., Anthony, D. C., Jiang, Y., Broom, K. A., Campbell, S. J., Tyler, D. J., van Kasteren, S. I., Davis, B. G., Sibson, N. R. (2009). Systemic Inflammatory Response Reactivates Immune-Mediated Lesions in Rat Brain. J. Neurosci. 29: 4820-4828 [Abstract] [Full Text]  
• Zamboni, P, Galeotti, R, Menegatti, E, Malagoni, A M, Tacconi, G, Dall'Ara, S, Bartolomei, I, Salvi, F (2009). Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 80: 392-399 [Abstract] [Full Text]  
• Becklund, B. R., Hansen, D. W. Jr., DeLuca, H. F. (2009). Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin. Proc. Natl. Acad. Sci. USA 106: 5276-5281 [Abstract] [Full Text]  
• Christophi, G. P., Hudson, C. A., Panos, M., Gruber, R. C., Massa, P. T. (2009). Modulation of Macrophage Infiltration and Inflammatory Activity by the Phosphatase SHP-1 in Virus-Induced Demyelinating Disease. J. Virol. 83: 522-539 [Abstract] [Full Text]  
• Moll, N. M., Cossoy, M. B., Fisher, E., Staugaitis, S. M., Tucky, B. H., Rietsch, A. M., Chang, A., Fox, R. J., Trapp, B. D., Ransohoff, R. M. (2009). Imaging Correlates of Leukocyte Accumulation and CXCR4/CXCL12 in Multiple Sclerosis. Arch Neurol 66: 44-53 [Abstract] [Full Text]  
• Johansson, S, Ytterberg, C, Gottberg, K, Widen Holmqvist, L, von Koch, L (2009). Use of health services in people with multiple sclerosis with and without fatigue. Mult Scler 15: 88-95 [Abstract]  
• Calabrese, M, Filippi, M, Rovaris, M, Bernardi, V, Atzori, M, Mattisi, I, Favaretto, A, Grossi, P, Barachino, L, Rinaldi, L, Romualdi, C, Perini, P, Gallo, P (2009). Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler 15: 36-41 [Abstract]  
• Omari, K. M., Lutz, S. E., Santambrogio, L., Lira, S. A., Raine, C. S. (2009). Neuroprotection and Remyelination after Autoimmune Demyelination in Mice that Inducibly Overexpress CXCL1. Am. J. Pathol. 174: 164-176 [Abstract] [Full Text]  
• Thangarajh, M, Gomez-Rial, J, Hedstrom, A., Hillert, J, Alvarez-Cermeno, J., Masterman, T, Villar, L. (2008). Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis. Mult Scler 14: 1208-1213 [Abstract]  
• Mo, C., Chearwae, W., O'Malley, J. T., Adams, S. M., Kanakasabai, S., Walline, C. C., Stritesky, G. L., Good, S. R., Perumal, N. B., Kaplan, M. H., Bright, J. J. (2008). Stat4 Isoforms Differentially Regulate Inflammation and Demyelination in Experimental Allergic Encephalomyelitis. J. Immunol. 181: 5681-5690 [Abstract] [Full Text]  
• Saresella, M., Marventano, I., Longhi, R., Lissoni, F., Trabattoni, D., Mendozzi, L., Caputo, D., Clerici, M. (2008). CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy. FASEB J. 22: 3500-3508 [Abstract] [Full Text]  
• Korenke, A. R, Rivey, M. P, Allington, D. R (2008). Sustained-Release Fampridine for Symptomatic Treatment of Multiple Sclerosis. The Annals of Pharmacotherapy 42: 1458-1465 [Abstract] [Full Text]  
• Shindler, K. S., Kenyon, L. C., Dutt, M., Hingley, S. T., Sarma, J. D. (2008). Experimental Optic Neuritis Induced by a Demyelinating Strain of Mouse Hepatitis Virus. J. Virol. 82: 8882-8886 [Abstract] [Full Text]  
• Alonso, A., Hernan, M. A. (2008). Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology 71: 129-135 [Abstract] [Full Text]  
• Nielsen, N., Frisch, M, Rostgaard, K, Wohlfahrt, J, Hjalgrim, H, Koch-Henriksen, N, Melbye, M, Westergaard, T (2008). Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark. Mult Scler 14: 823-829 [Abstract]  
• De Sarno, P., Axtell, R. C., Raman, C., Roth, K. A., Alessi, D. R., Jope, R. S. (2008). Lithium Prevents and Ameliorates Experimental Autoimmune Encephalomyelitis. J. Immunol. 181: 338-345 [Abstract] [Full Text]  
• Jilek, S., Schluep, M., Meylan, P., Vingerhoets, F., Guignard, L., Monney, A., Kleeberg, J., Le Goff, G., Pantaleo, G., Du Pasquier, R. A. (2008). Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain 131: 1712-1721 [Abstract] [Full Text]  
• Wust, S., van den Brandt, J., Tischner, D., Kleiman, A., Tuckermann, J. P., Gold, R., Luhder, F., Reichardt, H. M. (2008). Peripheral T Cells Are the Therapeutic Targets of Glucocorticoids in Experimental Autoimmune Encephalomyelitis. J. Immunol. 180: 8434-8443 [Abstract] [Full Text]  
• Killestein, J., Hartung, H.-P. (2008). Interferon {beta} in multiple sclerosis: predicting response at an early stage. J. Neurol. Neurosurg. Psychiatry 79: 616-617 [Full Text]  
• Hebb, A., Moore, C., Bhan, V, Campbell, T, Fisk, J., Robertson, H., Thorne, M, Lacasse, E, Holcik, M, Gillard, J, Crocker, S., Robertson, G. (2008). Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Mult Scler 14: 577-594 [Abstract]  
• Frohman, T. C., Galetta, S., Fox, R., Solomon, D., Straumann, D., Filippi, M., Zee, D., Frohman, E. M. (2008). Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology. Neurology 70: e57-e67 [Abstract] [Full Text]  
• Chen, J. W., Breckwoldt, M. O., Aikawa, E., Chiang, G., Weissleder, R. (2008). Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain 131: 1123-1133 [Abstract] [Full Text]  
• Sicotte, N. L., Kern, K. C., Giesser, B. S., Arshanapalli, A., Schultz, A., Montag, M., Wang, H., Bookheimer, S. Y. (2008). Regional hippocampal atrophy in multiple sclerosis. Brain 131: 1134-1141 [Abstract] [Full Text]  
• Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., Trebst, C., Stangel, M. (2008). Cortical Demyelination Is Prominent in the Murine Cuprizone Model and Is Strain-Dependent. Am. J. Pathol. 172: 1053-1061 [Abstract] [Full Text]  
• Leigh, R. J., Serra, A. (2008). Taking the temperature of MS with INO. Neurology 70: 1063-1064 [Full Text]  
• Villar, L., Garcia-Barragan, N., Espino, M., Roldan, E., Sadaba, M., Gomez-Rial, J., Gonzalez-Porque, P., Alvarez-Cermeno, J. (2008). Influence of oligoclonal IgM specificity in multiple sclerosis disease course. Mult Scler 14: 183-187 [Abstract]  
• Tsutsui, S., Vergote, D., Shariat, N., Warren, K., Ferguson, S. S. G., Power, C. (2008). Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and {beta}-arrestin-1 in monocytoid cells. FASEB J. 22: 786-796 [Abstract] [Full Text]  
• Pirko, I., Nolan, T. K., Holland, S. K., Johnson, A. J. (2008). Multiple Sclerosis: Pathogenesis and MR Imaging Features of T1 Hypointensities in Murine Model. Radiology 246: 790-795 [Abstract] [Full Text]  
• Soilu-Hanninen, M, Laaksonen, M, Laitinen, I, Eralinna, J-P, Lilius, E-M, Mononen, I (2008). A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 79: 152-157 [Abstract] [Full Text]  
• Kap, Y. S., Smith, P., Jagessar, S. A., Remarque, E., Blezer, E., Strijkers, G. J., Laman, J. D., Hintzen, R. Q., Bauer, J., Brok, H. P. M., 't Hart, B. A. (2008). Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34-56-Specific Cytotoxic T Cells. J. Immunol. 180: 1326-1337 [Abstract] [Full Text]  
• Minagar, A., Alexander, J. S., Schwendimann, R. N., Kelley, R. E., Gonzalez-Toledo, E., Jimenez, J. J., Mauro, L., Jy, W., Smith, S. J. (2008). Combination Therapy With Interferon Beta-1a and Doxycycline in Multiple Sclerosis: An Open-Label Trial. Arch Neurol 65: 199-204 [Abstract] [Full Text]  
• Frohman, E. M., Zivadinov, R. (2007). What you see is what you get: Coupling function with structure in the visual system. Neurology 69: 2119-2120 [Full Text]  
• Rocca, M. A., Pagani, E., Absinta, M., Valsasina, P., Falini, A., Scotti, G., Comi, G., Filippi, M. (2007). Altered functional and structural connectivities in patients with MS: A 3-T study. Neurology 69: 2136-2145 [Abstract] [Full Text]  
• Gundogan, F. C., Demirkaya, S., Sobaci, G. (2007). Is Optical Coherence Tomography Really a New Biomarker Candidate in Multiple Sclerosis? A Structural and Functional Evaluation. IOVS 48: 5773-5781 [Abstract] [Full Text]  
• Pohlau, D., Przuntek, H., Sailer, M., Bethke, F., Koehler, J., Konig, N., Heesen, C., Spath, P., Andresen, I. (2007). Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study. Mult Scler 13: 1107-1117 [Abstract]  
• Dutta, R., McDonough, J., Chang, A., Swamy, L., Siu, A., Kidd, G. J., Rudick, R., Mirnics, K., Trapp, B. D. (2007). Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients. Brain 130: 2566-2576 [Abstract] [Full Text]  
• Calabrese, M., De Stefano, N., Atzori, M., Bernardi, V., Mattisi, I., Barachino, L., Morra, A., Rinaldi, L., Romualdi, C., Perini, P., Battistin, L., Gallo, P. (2007). Detection of Cortical Inflammatory Lesions by Double Inversion Recovery Magnetic Resonance Imaging in Patients With Multiple Sclerosis. Arch Neurol 64: 1416-1422 [Abstract] [Full Text]  
• Williams, A., Piaton, G., Aigrot, M.-S., Belhadi, A., Theaudin, M., Petermann, F., Thomas, J.-L., Zalc, B., Lubetzki, C. (2007). Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?. Brain 130: 2554-2565 [Abstract] [Full Text]  
• Yu, K.-H., Yang, C.-H., Chu, C.-C. (2007). Swallowing disturbance due to isolated vagus nerve involvement in systemic lupus erythematosus. Lupus 16: 746-749 [Abstract]  
• Trojan, D., Arnold, D., Collet, J-P., Shapiro, S., Bar-Or, A., Robinson, A., Le Cruguel, J-P., Ducruet, T., Narayanan, S., Arcelin, K., Wong, A., Tartaglia, M., Lapierre, Y., Caramanos, Z., Da Costa, D. (2007). Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors. Mult Scler 13: 985-995 [Abstract]  
• Sobocki, P., Pugliatti, M., Lauer, K., Kobelt, G. (2007). Estimation of the cost of MS in Europe: Extrapolations from a multinational cost study. Mult Scler 13: 1054-1064 [Abstract]  
• Rose, J. W., Burns, J. B., Bjorklund, J., Klein, J., Watt, H. E., Carlson, N. G. (2007). Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results. Neurology 69: 785-789 [Abstract] [Full Text]  
• Shindler, K. S., Ventura, E., Rex, T. S., Elliott, P., Rostami, A. (2007). SIRT1 Activation Confers Neuroprotection in Experimental Optic Neuritis. IOVS 48: 3602-3609 [Abstract] [Full Text]  
• Glass-Marmor, L., Paperna, T., Ben-Yosef, Y., Miller, A. (2007). Chronotherapy using corticosteroids for multiple sclerosis relapses. J. Neurol. Neurosurg. Psychiatry 78: 886-888 [Abstract] [Full Text]  
• Nessler, S., Boretius, S., Stadelmann, C., Bittner, A., Merkler, D., Hartung, H.-P., Michaelis, T., Bruck, W., Frahm, J., Sommer, N., Hemmer, B. (2007). Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage. Brain 130: 2186-2198 [Abstract] [Full Text]  
• Greer, D. M., Cagliero, E., Krakauer, E. L., Gonzalez, R. G., Hedley-Whyte, E. T. (2007). Case 21-2007 -- A 58-Year-Old Woman with Headaches, Weakness, and Strokelike Episodes. NEJM 357: 164-173 [Full Text]  
• Pelayo, R., Tintore, M., Rovira, A., Rio, J., Nos, C., Grive, E., Tellez, N., Comabella, M., Montalban, X. (2007). Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort. Mult Scler 13: 731-736 [Abstract]  
• Alanoglu, G., Kilbas, S., Arslan, C., Senol, A., Kutluhan, S. (2007). Autoimmune hemolytic anemia during interferon-beta-I b treatment for multiple sclerosis. Mult Scler 13: 683-685 [Abstract]  
• Rossi, C., Padmanaban, D., Ni, J., Yeh, L.-A., Glicksman, M. A., Waldner, H. (2007). Identifying Druglike Inhibitors of Myelin-Reactive T Cells by Phenotypic High-Throughput Screening of a Small-Molecule Library. J Biomol Screen 12: 481-489 [Abstract]  
• Dutta, R., Trapp, B. D. (2007). Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68: S22-S31 [Abstract] [Full Text]  
• Hamamcioglu, K., Reder, A. (2007). Interferon-{beta} regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis. Mult Scler 13: 459-470 [Abstract]  
• Martinez, A., Sanchez-Lopez, M., Varade, J., Mas, A., Carmen Martin, M, de las Heras, V., Arroyo, R., Luis Mendoza, J., Diaz-Rubio, M., Fernandez-Gutierrez, B., de la Concha, E. G, Urcelay, E. (2007). Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis 66: 325-329 [Abstract] [Full Text]  
• Benito, C., Romero, J. P., Tolon, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., Romero, J. (2007). Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis. J. Neurosci. 27: 2396-2402 [Abstract] [Full Text]  
• Dunn, S. E., Ousman, S. S., Sobel, R. A., Zuniga, L., Baranzini, S. E., Youssef, S., Crowell, A., Loh, J., Oksenberg, J., Steinman, L. (2007). Peroxisome proliferator-activated receptor (PPAR){alpha} expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. JEM 204: 321-330 [Abstract] [Full Text]  
• Mameli, G., Astone, V., Arru, G., Marconi, S., Lovato, L., Serra, C., Sotgiu, S., Bonetti, B., Dolei, A. (2007). Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6. J. Gen. Virol. 88: 264-274 [Abstract] [Full Text]  
• Amend, B., Doster, H., Lange, C., Dubois, E., Kalbacher, H., Melms, A., Bischof, F. (2006). Induction of Autoimmunity by Expansion of Autoreactive CD4+CD62Llow Cells In Vivo. J. Immunol. 177: 4384-4390 [Abstract] [Full Text]  
• Gladstone, D. E., Zamkoff, K. W., Krupp, L., Peyster, R., Sibony, P., Christodoulou, C., Locher, E., Coyle, P. K. (2006). High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis. Arch Neurol 63: 1388-1393 [Abstract] [Full Text]  
• Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., Radue, E. W., the FTY720 D2201 Study Group, (2006). Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis. NEJM 355: 1124-1140 [Abstract] [Full Text]  
• Shindler, K. S, Guan, Y., Ventura, E., Bennett, J., Rostami, A. (2006). Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis. Mult Scler 12: 526-532 [Abstract]  
• Zwemmer, J N., Berkhof, J, Castelijns, J A, Barkhof, F, Polman, C H, Uitdehaag, B M. (2006). Classification of multiple sclerosis patients by latent class analysis of magnetic resonance imaging characteristics. Mult Scler 12: 565-572 [Abstract]  
• Shriver, L. P., Dittel, B. N. (2006). T-Cell-Mediated Disruption of the Neuronal Microtubule Network: Correlation with Early Reversible Axonal Dysfunction in Acute Experimental Autoimmune Encephalomyelitis. Am. J. Pathol. 169: 999-1011 [Abstract] [Full Text]  
• Mikaeloff, Y., Caridade, G., Assi, S., Suissa, S., Tardieu, M., on behalf of the KIDSEP Study Group, (2006). Prognostic Factors for Early Severity in a Childhood Multiple Sclerosis Cohort. Pediatrics 118: 1133-1139 [Abstract] [Full Text]  
• Herrmann, I., Kellert, M., Schmidt, H., Mildner, A., Hanisch, U. K., Bruck, W., Prinz, M., Nau, R. (2006). Streptococcus pneumoniae Infection Aggravates Experimental Autoimmune Encephalomyelitis via Toll-Like Receptor 2.. Infect. Immun. 74: 4841-4848 [Abstract] [Full Text]  
• Rinaldi, L., Gallo, P., Calabrese, M., Ranzato, F., Luise, D., Colavito, D., Motta, M., Guglielmo, A., Del Giudice, E., Romualdi, C., Ragazzi, E., D'Arrigo, A., Dalle Carbonare, M., Leontino, B., Leon, A. (2006). Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.. Brain 129: 1993-2007 [Abstract] [Full Text]  
• Friese, M. A., Montalban, X., Willcox, N., Bell, J. I., Martin, R., Fugger, L. (2006). The value of animal models for drug development in multiple sclerosis. Brain 129: 1940-1952 [Abstract] [Full Text]  
• Lehmann, H. C., Hartung, H.-P., Hetzel, G. R., Stuve, O., Kieseier, B. C. (2006). Plasma exchange in neuroimmunological disorders: part 1: rationale and treatment of inflammatory central nervous system disorders.. Arch Neurol 63: 930-935 [Abstract] [Full Text]  
• Fahey, A. J., Robins, R. A., Kindle, K. B., Heery, D. M., Constantinescu, C. S. (2006). Effects of glucocorticoids on STAT4 activation in human T cells are stimulus-dependent. J. Leukoc. Biol. 80: 133-144 [Abstract] [Full Text]  
• Nielsen, N. M., Westergaard, T., Frisch, M., Rostgaard, K., Wohlfahrt, J., Koch-Henriksen, N., Melbye, M., Hjalgrim, H. (2006). Type 1 diabetes and multiple sclerosis: a danish population-based cohort study.. Arch Neurol 63: 1001-1004 [Abstract] [Full Text]  
• Rauer, S, Euler, B, Reindl, M, Berger, T (2006). Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.. J. Neurol. Neurosurg. Psychiatry 77: 739-742 [Abstract] [Full Text]  
• Rajda, C, Bencsik, K, Fuvesi, J, Seres, E, Vecsei, L, Bergquist, J (2006). The norepinephrine level is decreased in the lymphocytes of long-term interferon-beta-treated multiple sclerosis patients. Mult Scler 12: 265-270 [Abstract]  
• Alonso, A., Jick, S. S., Jick, H., Hernan, M. A. (2006). Antibiotic Use and Risk of Multiple Sclerosis. Am J Epidemiol 163: 997-1002 [Abstract] [Full Text]  
• Dousset, V., Brochet, B., Deloire, M.S.A., Lagoarde, L., Barroso, B., Caille, J.-M., Petry, K.G. (2006). MR Imaging of Relapsing Multiple Sclerosis Patients Using Ultra-Small-Particle Iron Oxide and Compared with Gadolinium.. Am. J. Neuroradiol. 27: 1000-1005 [Abstract] [Full Text]  
• Pittock, S. J., Weinshenker, B. G., Noseworthy, J. H., Lucchinetti, C. F., Keegan, M., Wingerchuk, D. M., Carter, J., Shuster, E., Rodriguez, M. (2006). Not every patient with multiple sclerosis should be treated at time of diagnosis.. Arch Neurol 63: 611-614 [Full Text]  
• Dimitri, D., Benveniste, O., Dubourg, O., Maisonobe, T., Eymard, B., Amoura, Z., Jean, L., Tiev, K., Piette, J.-C., Klatzmann, D., Herson, S., Boyer, O. (2006). Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis. Brain 129: 986-995 [Abstract] [Full Text]  
• Paintlia, A. S., Paintlia, M. K., Singh, I., Singh, A. K. (2006). IL-4-Induced Peroxisome Proliferator-Activated Receptor {gamma} Activation Inhibits NF-{kappa}B Trans Activation in Central Nervous System (CNS) Glial Cells and Protects Oligodendrocyte Progenitors under Neuroinflammatory Disease Conditions: Implication for CNS-Demyelinating Diseases. J. Immunol. 176: 4385-4398 [Abstract] [Full Text]